Immunocytochemical markers in acute leukaemias diagnosis

Experimental Oncology

Volumn 32, Issue 3, 2010, Pages 195-199

  Gluzman, D F ^a   Nadgornaya, V A ^a   Sklyarenko, L M ^a   Ivanovskaya, T S ^a   Poludnenko, L Yu ^a   Ukrainskaya, N I ^a  

^a R E KAVETSKY INSTITUTE OF EXPERIMENTAL PATHOLOGY   (Ukraine)

Author keywords

Acute leukaemias; Classification; Diagnosis; Immunophenotyping

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE MEGAKARYOCYTIC LEUKEMIA; ACUTE MYELOBLASTIC LEUKEMIA; ARTICLE; CELL SURFACE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOPHENOTYPING; MAJOR CLINICAL STUDY; PROMYELOCYTIC LEUKEMIA; UKRAINE;

ACUTE DISEASE; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; LEUKEMIA, MYELOID, ACUTE; LYMPHOCYTE SUBSETS; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; TUMOR MARKERS, BIOLOGICAL;

EID: 77957744091     PISSN: 18129269     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Bennet JM, Catovsky D, Daniel MT, et al. Proposals for the classification of the acute leukemias. French-American-British (FAB) Cooperative Group. Br J Hematol 1976; 33: 451-8.
2. Bennet JM, Catovsky D, Daniel MT, et al. Proposed revised criteria for the classification of acute myeloid leukaemia: A report of the French-American-British Cooperative Group. Ann Intern Med 1985; 103: 620-5.
3. Bain BJ. Leukaemia diagnosis. Oxford: Blackwell Seience Ltd 1999. 200 p.
4. Jaffe ES, Harris NL, Stein H, Vardiman JW, eds. World Health Organization classification of tumours. Pathology and genetics of tumours of haematopoetic and lymphoid tissues. Lyon: IARC 2001. 351 p.
5. Swerdlow SH, Campo E, Harris NL, et al, eds. WHO classification of tumours of haematopoetic and lymphoid tissues. Lyon: IARC 2008. 439 p.
6. Vardiman JW, Thiel J, Arber DA, et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukaemia: rationale and important changes. Blood 2009; 114: 937-51.
7. Passegue E, Jamieson CHM, Ailles LE, et al. Normal and leukaemic hematopoesis: are leukaemias a stem cell disorder or a reacquisition of stem cell characteristics? Proc Natl Acad Sci USA 2003; 100: 11842-9.
8. Wang JCY, Dick JE. Cancer stem cells. In: Principles and practice of oncology, 8th ed. Lippincot Williams a Wilkins, 2008: 136-45.
9. Gluzman DF, Abramenko IV, Sklyarenko LM, et al. Leukaemia diagnosis. Atlas and practical manual. Kyiv: Morion 2000. 224 p. (In Russian).
10. Gluzman DF, Imamura N, Sklyarenko LM, et al. Malignant diseases of hematopoetic and lymphoid tissues in Chernobyl clean-up workers. The Hematol J 2005; 5: 565-71. (Pubitemid 40309621)
11. Gluzman DF, Nadgornaya VA, Sklyarenko LM, et al. Study of morphocytochemical and immunophenotypic features of acute leukaemia stem cells. Exp Oncol 2008; 30: 102-5.
12. Döhner H, Estey EH, Amadori S, et al. Diagnosis and management of acute myeloid leukaemia in adults: recommendation from an international expert panel, on behalf of the European Leukemia/Net. Blood 2010; 115: 453-74.
13. Yamamoto JF, Goodman MT. Patterns of leukemia incidence in the United States by subtype and demographic characteristics, 1997-2002. Cancer Causes Control 2008; 19: 379-90.
14. Haferlach T, Schoch C, Löffler H, et al. Morphologic dysplasia in de novo acute myeloid leukemia (AML) is related to unfavorable cytogenetics but has no independent prognostic relevance under the conditions of intensive induction therapy: results of a multiparameter analysis from the German AML Cooperative Group studies. J Clin Oncology 2003; 21: 256-65. (Pubitemid 46606154)